Literature DB >> 20670816

Atopic dermatitis and keratoconjunctivitis.

Brett Bielory1, Leonard Bielory.   

Abstract

Atopic dermatitis, a chronic disease seen by allergist-immunologists, has both dermatologic and ocular manifestations. The ocular component is often disproportionately higher than the dermatologic disease. Even if skin abnormalities seem well controlled, these patients require ophthalmic evaluation. Atopic keratoconjunctivitis in atopic dermatitis patients is characterized by acute exacerbations and requires maintenance therapy for long-term control. Future studies will continue to emphasize the use of steroid-sparing, immunomodulating agents that have the potential to provide long-lasting anti-inflammatory control with a more favorable side-effect profile. Copyright 2010 Elsevier Inc. All rights reserved.

Entities:  

Mesh:

Substances:

Year:  2010        PMID: 20670816     DOI: 10.1016/j.iac.2010.06.004

Source DB:  PubMed          Journal:  Immunol Allergy Clin North Am        ISSN: 0889-8561            Impact factor:   3.479


  24 in total

Review 1.  [Pathophysiology of atopic blepharokeratoconjunctivitis].

Authors:  T Lapp; P Maier; T Jakob; T Reinhard
Journal:  Ophthalmologe       Date:  2017-06       Impact factor: 1.059

Review 2.  T helper subsets in allergic eye disease.

Authors:  Nancy J Reyes; Daniel R Saban
Journal:  Curr Opin Allergy Clin Immunol       Date:  2014-10

3.  Atopic Keratoconjunctivitis: Pharmacotherapy for the Elderly.

Authors:  Erminia Ridolo; P Kihlgren; I Pellicelli; M C Nizi; F Pucciarini; C Incorvaia
Journal:  Drugs Aging       Date:  2019-07       Impact factor: 3.923

Review 4.  [Ocular involvement in atopic dermatitis : Clinical aspects and therapy].

Authors:  P Maier; T Lapp; T Reinhard
Journal:  Ophthalmologe       Date:  2017-06       Impact factor: 1.059

Review 5.  Systemic diseases and the cornea.

Authors:  Ruchi Shah; Cynthia Amador; Kati Tormanen; Sean Ghiam; Mehrnoosh Saghizadeh; Vaithi Arumugaswami; Ashok Kumar; Andrei A Kramerov; Alexander V Ljubimov
Journal:  Exp Eye Res       Date:  2021-01-21       Impact factor: 3.467

6.  Ocular allergy in the Asia Pacific region.

Authors:  Constance H Katelaris
Journal:  Asia Pac Allergy       Date:  2011-10-06

7.  Dupilumab-Associated Ocular Surface Disease: Clinical Characteristics, Treatment, and Follow-Up.

Authors:  Austin Bohner; Christina Topham; Jennifer Strunck; Dylan Haynes; Molly Brazil; John Clements; Eric Simpson; Winston Chamberlain
Journal:  Cornea       Date:  2021-05-01       Impact factor: 3.152

Review 8.  Allergic conjunctivitis: a comprehensive review of the literature.

Authors:  Mario La Rosa; Elena Lionetti; Michele Reibaldi; Andrea Russo; Antonio Longo; Salvatore Leonardi; Stefania Tomarchio; Teresio Avitabile; Alfredo Reibaldi
Journal:  Ital J Pediatr       Date:  2013-03-14       Impact factor: 2.638

9.  Management of Ocular Manifestations of Atopic Dermatitis: A Consensus Meeting Using a Modified Delphi Process.

Authors:  Jacob P Thyssen; Steffen Heegaard; Lena Ivert; Anita Remitz; Tove Agner; Marjolein De Bruin-Weller; Theis Huldt-Nystrøm; Laura Korhonen; Lina U Ivert; Pekka Leinonen; Johanna Mandelin; Tore Särnhult; Thomas Schopf; Eirik Sundlisæter; Simon F Thomsen; Thrasyvoulos Tzellos; Christian Vestergaard; Laura von Kobyletzki; Maria Bradley
Journal:  Acta Derm Venereol       Date:  2020-09-16       Impact factor: 3.875

Review 10.  Potential Biomarkers for Allergic Conjunctival Diseases.

Authors:  Neeta Roy; Shir Levanon; Penny A Asbell
Journal:  Eye Contact Lens       Date:  2020-03       Impact factor: 3.152

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.